Adaptation of the PROFFIT Instrument Into Turkish: A Validity and Reliability Study

NCT07088978 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2025-10-02

No results posted yet for this study

Summary

The aim of this study is to evaluate the Turkish validity and reliability of the Patient Reported Outcomes for Fighting Financial Toxicity of Cancer (PROFFIT) developed in Italy.

Conditions

Sponsors & Collaborators

  • Giresun Training and Research Hospital

    collaborator UNKNOWN
  • St. Mary's University, Twickenham

    collaborator OTHER
  • Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale

    collaborator NETWORK
  • Akdeniz University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-31
Primary Completion
2026-02-28
Completion
2026-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07088978 on ClinicalTrials.gov